Skip to main content

Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41

Publication ,  Journal Article
Montgomery, DL; Wang, YJ; Hrin, R; Luftig, M; Su, B; Miller, MD; Wang, F; Haytko, P; Huang, L; Vitelli, S; Condra, J; Liu, X; Hampton, R ...
Published in: mAbs
September 1, 2009

The human D5 monoclonal antibody binds to the highly conserved hydrophobic pocket on the N-terminal heptad repeat (NHR) trimer of HIV-1 gp41 and exhibits modest yet relatively broad neutralization activity. Both binding and neutralization depend on residues in the complementarity determining regions (CDRs) of the D5 IgG variable domains on heavy chain (VH) and light chain (VL). In an effort to increase neutralization activity to a wider range of HIV-1 strains, we have affinity matured the parental D5 scFv by randomizing selected residues in 5 of its 6 CDRs. The resulting scFv variants derived from four different CDR changes showed enhanced binding affinities to gp41 NHR mimetic (5-helix) which correlated to improved neutralization potencies by up to 8-fold. However, when converted to IgG1s, these D5 variants had up to a 12-fold reduction in neutralization potency over their corresponding scFvs despite their slightly enhanced in vitro binding affinities. Remarkably, D5 variant IgG1s bearing residue changes in CDRs that interact with epitope residues N-terminal to the hydrophobic pocket (such as VH CDR3 and VL CDR3) retained more neutralization potency than those containing residue changes in pocketinteracting CDRs (such as VH CDR2). These results provide compelling evidence for the existence of a steric block to an IgG that extends to the gp41 NHR hydrophobic pocket region, and can be a useful guide for developing therapeutic antibodies and vaccines circumventing this block. © 2009 Landes Bioscience.

Duke Scholars

Published In

mAbs

ISSN

1942-0862

Publication Date

September 1, 2009

Volume

1

Issue

5

Start / End Page

458 / 469

Related Subject Headings

  • Immunology
  • 3214 Pharmacology and pharmaceutical sciences
  • 3204 Immunology
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1107 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Montgomery, D. L., Wang, Y. J., Hrin, R., Luftig, M., Su, B., Miller, M. D., … An, Z. (2009). Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41. MAbs, 1(5), 458–469.
Montgomery, D. L., Y. J. Wang, R. Hrin, M. Luftig, B. Su, M. D. Miller, F. Wang, et al. “Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41.” MAbs 1, no. 5 (September 1, 2009): 458–69.
Montgomery DL, Wang YJ, Hrin R, Luftig M, Su B, Miller MD, et al. Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41. mAbs. 2009 Sep 1;1(5):458–69.
Montgomery, D. L., et al. “Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41.” MAbs, vol. 1, no. 5, Sept. 2009, pp. 458–69.
Montgomery DL, Wang YJ, Hrin R, Luftig M, Su B, Miller MD, Wang F, Haytko P, Huang L, Vitelli S, Condra J, Liu X, Hampton R, Carfi A, Pessi A, Bianchi E, Joyce J, Lloyd C, Geleziunas R, Bramhill D, King VM, Finnefrock AC, Strohl W, An Z. Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41. mAbs. 2009 Sep 1;1(5):458–469.

Published In

mAbs

ISSN

1942-0862

Publication Date

September 1, 2009

Volume

1

Issue

5

Start / End Page

458 / 469

Related Subject Headings

  • Immunology
  • 3214 Pharmacology and pharmaceutical sciences
  • 3204 Immunology
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1107 Immunology